The analysis of the potential role of FIP200 in tumor development has focused, for the most part, on breast cancer [7], [22], [23], and there has been one report of the effects of transient downregulation of FIP200 in breast tumor cells [7]. This evidence concerns the gene RB1CC1 and breast neoplasm.